Reticulocyte and Erythrocyte Hemoglobin Parameters for Iron Deficiency and Anemia Diagnostics in Patient Blood Management. A Narrative Review.
Christian HoenemannNorbert OstendorfAlexander ZarbockDietrich DollOlaf HagemannMathias ZimmermannMarkus Martin LuediPublished in: Journal of clinical medicine (2021)
Anemia, iron deficiency and other hematinic deficiencies are a major cause of perioperative transfusion needs and are associated with increased morbidity and mortality. Anemia can be caused either by decreased production of hemoglobin or red blood cells or by increased consumption and blood loss. Decreased production can involve anything from erythropoietin or vitamin B12 insufficiency to absolute or functional lack of iron. Thus, to achieve the goal of patient blood management, anemia must be addressed by addressing its causes. The traditional parameters to diagnose anemia, despite offering elaborate options, are not ideally suited to giving a simple overview of the causes of anemia, e.g., iron status for erythropoiesis, especially during the acute phase of inflammation, acute blood loss or iron deficiency. Reticulocyte hemoglobin can thus help to uncover the cause of the anemia and to identify the main factors inhibiting erythropoiesis. Regardless of the cause of anemia, reticulocyte hemoglobin can also quickly track the success of therapy and, together with the regular full blood count it is measured alongside, help in clearing the patient for surgery.
Keyphrases
- iron deficiency
- red blood cell
- case report
- oxidative stress
- cardiac surgery
- minimally invasive
- stem cells
- coronary artery disease
- liver failure
- intensive care unit
- patients undergoing
- mesenchymal stem cells
- acute respiratory distress syndrome
- percutaneous coronary intervention
- sickle cell disease
- extracorporeal membrane oxygenation
- mechanical ventilation